Sarah Sloot, MD, Omar M. Rashid, MD, JD, Amod A. Sarnaik, MD, and Jonathan S. Zager, MD

All articles by Sarah Sloot, MD, Omar M. Rashid, MD, JD, Amod A. Sarnaik, MD, and Jonathan S. Zager, MD

Developments in Intralesional Therapy for Metastatic Melanoma

May 13, 2016

[Cancer Control] This research explores the efficacy of intralesional therapy as a treatment option for patients with unresectable, locally advanced, or metastatic melanoma.

Next post in Melanoma

Sarah Sloot, MD, Omar M. Rashid, MD, JD, Amod A. Sarnaik, MD, and Jonathan S. Zager, MD

All articles by Sarah Sloot, MD, Omar M. Rashid, MD, JD, Amod A. Sarnaik, MD, and Jonathan S. Zager, MD

Developments in Intralesional Therapy for Metastatic Melanoma

Pembrolizumab Achieves Response and Increased Survival in Melanoma